Binding of two novel bisdaunorubicins to DNA studied by NMR spectroscopy

Biochemistry

Volumn 36, Issue 29, 1997, Pages 8663-8670

  Robinson, Howard ^a   Priebe, Waldemar ^b   Chaires, Jonathan B ^c   Wang, Andrew H J ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC ANTIBIOTIC; DAUNORUBICIN; DAUNORUBICIN DERIVATIVE; DNA; ECHINOMYCIN; NUCLEOTIDE; TRIOSTINE A; UNCLASSIFIED DRUG; WP 631; WP 652;

ARTICLE; BINDING AFFINITY; CRYSTAL STRUCTURE; DNA SEQUENCE; DRUG CONFORMATION; DRUG DNA BINDING; MULTIDRUG RESISTANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR OVERHAUSER EFFECT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANTIBIOTICS, ANTINEOPLASTIC; BINDING SITES; DAUNORUBICIN; DNA; DRUG DESIGN; INTERCALATING AGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, CHEMICAL; MODELS, MOLECULAR; SEQUENCE ANALYSIS, DNA;

EID: 0030840016     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi970842j     Document Type: Article

References (25)

1. Brownlee, R. T. C., Cacioli, P., Chandler, C. J., Phillips, D. R., Scourides, P. A., & Reiss, J. A. (1986) J. Chem. Soc., Chem. Commun. 659-661.
2. Brünger, A. (1993) X-PLOR (version 3.1), The Howard Hughes Medical Institute and Yale University, New Haven, CT.
3. Chaires, J. B., Satyanarayana, S., Suh, D., Fokt, I., Przewloka, T., & Priebe, W. (1996) Biochemistry 35, 2047-2053.
4. Chaires J. B., Leng, F., Przewloka, T., Fokt, I., Ling, Y.-H., Perez-Soler, R. & Priebe, W. (1997) J. Med. Chem. 40, 261-266.
5. Gao, Y.-G., & Wang, A. H.-J. (1995) J. Biomol. Struct. Dyn. 13, 103-117.
6. Gao, Y.-G., Liaw, Y.-C., Li, Y.-K., van der Marel, G. A., van Boom, J. H., & Wang, A. H.-J. (1991) Proc. Natl. Acad. Sci. 88, 4845-4849.
7. Gao, Y.-G., Priebe, W., & Wang, A. H.-J. (1996) Eur. J. Biochem. 240, 331-335.
8. Henry, D. W., & Tong, G. L. (1978) U.S. Patent 4 112 217, September 5.
9. Hore, P. J. (1983) J. Magn. Reson. 54, 539-542.
10. Kochoyan, M., Leroy, J. L., & Gueron, M. (1990) Biochemistry 29, 4799-4805.
11. Post, C. B., Meadows, R. P., and Gorenstein, D. G. (1990) J. Am. Chem. Soc. 112, 6796-6803.
12. Priebe, W. (1996) Curr. Pharm. Des. 1, 51-68.
13. Priebe, W., & Perez-Soler, R. (1993) Pharm. Ther. 60, 215-234.
14. Priebe, W., Skibicki, P., Varela, O., Neamati, N. M. S., Dziewiszek, K., Grynkiewicz, G., Horton, D., Zou, Y., Ling, Y.-H., & Perez-Soler, R. (1995) in Anthracycline Antibiotics. Novel Analogues, Methods of delivery, and Mechanisms of Action (Priebe, W., Ed.) pp 14-46 American Chemical Society, Washington, DC.
15. Priebe, W., Chaires, J. B., Przewloka, T., Fokt, I., Krawczyk, M., Grynkiewica, G., Ling, Y.-H., Zou, Y., & Perez-Soler, R. (1996) Proc. Am. Chem. Soc. Meet. 211, CARB-16, March 24-28, New Orleans.
16. Robinson, H., & Wang, A. H.-J. (1992) Biochemistry 31, 3524-3533.
17. Seshadri, R., Israel, M., & Pegg, W. (1983) J. Med. Chem. 26, 11.
18. Sklenar, V., Brooks, B. R., Zon, G., & Bax, A. (1987) J. Magn. Reson. 75, 352-357.
19. Skorobogaty, A., Brownlee, R. T. C., Chandler, C. J., Kyratzis, I., Phillips, D. R., Reiss, J. A., & Trist, H. (1988) Anti-Cancer Drug Des. 3, 41-56.
20. States, D. J., Haberkorn, R. A., & Ruben, D. J. (1982) J. Magn. Reson. 48, 286-292.
21. Valentini, L., Nicolella, V., Vannini, E., Menozzi, M., Penco, S., & Arcamone, F. (1985) Farmaco, Ed. Sci. 40, 377-390.
22. Wang, A. H.-J. (1992) Curr. Opin. Struct. Biol. 2, 361-368.
23. Wang, A. H.-J., Ughetto, G., Quigley, G. J., Hakoshima, T., van der Marel, G. A., van Boom, J. H., & Rich, A. (1984) Science 225, 1115-1121.
24. Wang, A. H.-J., Ughetto, G., Quigley, G. J., & Rich, A. (1987) Biochemistry 26, 1152-1163.
25. Wang, A. H.-J., Gao, Y.-G., Liaw, Y.-C., & Li, Y.-K. (1991) Biochemistry 30, 3812-3815.